Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
"One pill, once daily": What clinicians need to know about Atripla™
Overview
Fingerprint
Fingerprint
Dive into the research topics of '"One pill, once daily": What clinicians need to know about Atripla™'. Together they form a unique fingerprint.
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Medicine & Life Sciences
100%
Once Daily
Chemical Compounds
81%
Antiretroviral
Chemical Compounds
70%
Pharmacokinetics
Engineering & Materials Science
46%
pharmaceutical
Social Sciences
45%
clinician
Social Sciences
42%
Drug products
Engineering & Materials Science
35%
clinical use
Social Sciences
33%
Cite this